Objective <p>This study was designed to test for perioperative complications, mortality, and length of stay after cystectomy for nonbladder cancer (non-BCa) v radical cystectomy (RC) for bladder cancer (BCa).</p> Methods <p>Patients were identified within the National Inpatient Sample (2000–2019). Multivariable logistic and Poisson regression models were fitted.</p> Results <p>Of 26,721 cystectomy patients, 1314 (5%) harbored non-BCa diagnosis: 515 (39%) neurogenic bladder; 379 (29%) radiation cystitis; 238 (18%) interstitial cystitis; 181 (14%) bladder fistula. Relative to RC for BCa, cystectomy for neurogenic bladder, radiation cystitis and bladder fistula resulted in higher genitourinary (22–39 vs. 14%; multivariable odds ratios [MOR] 1.7–3.8), infectious (7–8 vs. 4%; MOR 1.5–2.3), and wound (9 vs. 5%; MOR 1.5–2.0) complications rates. Only cystectomy for neurogenic bladder resulted in higher pulmonary complications (15 vs. 11%; MOR 1.8). Additionally, cystectomy for neurogenic bladder and bladder fistula independently predicted 1.5-fold higher rate of critical care therapy (CCT) use, but only cystectomy for neurogenic bladder exhibited 2.4-fold higher in-hospital mortality rate. Finally, cystectomy for neurogenic bladder, radiation cystitis, and bladder fistula resulted in higher rates of hospital stay ≥ 75th percentile (33–47 vs. 27%; MOR 1.7–2.8).</p> Conclusions <p>Relative to RC for BCa, cystectomy for three of four non-BCa conditions resulted in higher rates of four of 12 in-hospital adverse outcomes. Additionally, cystectomy for two of four non-BCa conditions resulted in higher CCT use, but only cystectomy for neurogenic bladder predicted higher rate of in-hospital mortality.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Perioperative Complications and In-hospital Mortality After Cystectomy for Nonbladder Cancer Conditions Versus Radical Cystectomy for Bladder Cancer

  • Natali Rodriguez Peñaranda,
  • Mario de Angelis,
  • Carolin Siech,
  • Francesco Di Bello,
  • Jordan A. Goyal,
  • Zhe Tian,
  • Fred Saad,
  • Shahrokh F. Shariat,
  • Nicola Longo,
  • Alberto Briganti,
  • Felix K. H. Chun,
  • Stefano Di Bari,
  • Stefano Puliatti,
  • Salvatore Micali,
  • Pierre I. Karakiewicz

摘要

Objective

This study was designed to test for perioperative complications, mortality, and length of stay after cystectomy for nonbladder cancer (non-BCa) v radical cystectomy (RC) for bladder cancer (BCa).

Methods

Patients were identified within the National Inpatient Sample (2000–2019). Multivariable logistic and Poisson regression models were fitted.

Results

Of 26,721 cystectomy patients, 1314 (5%) harbored non-BCa diagnosis: 515 (39%) neurogenic bladder; 379 (29%) radiation cystitis; 238 (18%) interstitial cystitis; 181 (14%) bladder fistula. Relative to RC for BCa, cystectomy for neurogenic bladder, radiation cystitis and bladder fistula resulted in higher genitourinary (22–39 vs. 14%; multivariable odds ratios [MOR] 1.7–3.8), infectious (7–8 vs. 4%; MOR 1.5–2.3), and wound (9 vs. 5%; MOR 1.5–2.0) complications rates. Only cystectomy for neurogenic bladder resulted in higher pulmonary complications (15 vs. 11%; MOR 1.8). Additionally, cystectomy for neurogenic bladder and bladder fistula independently predicted 1.5-fold higher rate of critical care therapy (CCT) use, but only cystectomy for neurogenic bladder exhibited 2.4-fold higher in-hospital mortality rate. Finally, cystectomy for neurogenic bladder, radiation cystitis, and bladder fistula resulted in higher rates of hospital stay ≥ 75th percentile (33–47 vs. 27%; MOR 1.7–2.8).

Conclusions

Relative to RC for BCa, cystectomy for three of four non-BCa conditions resulted in higher rates of four of 12 in-hospital adverse outcomes. Additionally, cystectomy for two of four non-BCa conditions resulted in higher CCT use, but only cystectomy for neurogenic bladder predicted higher rate of in-hospital mortality.